Xarelto and DYSPNOEA

7,247 reports of this reaction

2.4% of all Xarelto reports

#4 most reported adverse reaction

Overview

DYSPNOEA is the #4 most commonly reported adverse reaction for Xarelto, manufactured by Janssen Pharmaceuticals, Inc.. There are 7,247 FDA adverse event reports linking Xarelto to DYSPNOEA. This represents approximately 2.4% of all 302,183 adverse event reports for this drug.

Patients taking Xarelto who experience dyspnoea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

DYSPNOEA7,247 of 302,183 reports

DYSPNOEA is a less commonly reported adverse event for Xarelto, but still significant enough to appear in the safety profile.

Other Side Effects of Xarelto

In addition to dyspnoea, the following adverse reactions have been reported for Xarelto:

GASTROINTESTINAL HAEMORRHAGE — 21,611 reports
OFF LABEL USE — 7,869 reports
HAEMORRHAGE — 7,752 reports
EPISTAXIS — 6,737 reports
FATIGUE — 6,637 reports
DEATH — 6,098 reports
FALL — 6,062 reports
PULMONARY EMBOLISM — 5,988 reports
DRUG INEFFECTIVE — 5,858 reports
ANAEMIA — 5,642 reports

Other Drugs Associated with DYSPNOEA

The following drugs have also been linked to dyspnoea in FDA adverse event reports:

0XYGEN ABEMACICLIB ABIRATERONE ACETATE ACALABRUTINIB ACETAMINOPHEN ACETAMINOPHEN 325 MG ACETAMINOPHEN 325MG ACETAMINOPHEN 500 MG ACETAMINOPHEN 500MG ACETAMINOPHEN AND CODEINE PHOSPHATE ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE ACETAMINOPHEN AND PHENYLEPHRINE HYDROCHLORIDE ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL ACETAMINOPHEN, DEXTROMETHORPHAN HBR ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCL ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL ACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE

Frequently Asked Questions

Does Xarelto cause DYSPNOEA?

DYSPNOEA has been reported as an adverse event in 7,247 FDA reports for Xarelto. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is DYSPNOEA with Xarelto?

DYSPNOEA accounts for approximately 2.4% of all adverse event reports for Xarelto, making it a notable side effect.

What should I do if I experience DYSPNOEA while taking Xarelto?

If you experience dyspnoea while taking Xarelto, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Xarelto Full Profile All Drugs Causing DYSPNOEA Janssen Pharmaceuticals, Inc. Drugs

Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.